top of page

Grann Pharmaceuticals

Advanced Nucleic Acid Therapeutics

Our Vision

At Grann Pharmaceuticals, our commitment to the research and development of mRNA lipid nanoparticles drives us to continuously push the boundaries of what is possible in the current field of nanotechnology, delivering innovative small molecule treatments to create a positive impact on the lives of people worldwide.

Problem

Millions of people in the United States and globally are afflicted by diseases caused by single protein knockouts and mutations.

Myoglobin.png
Screenshot 2024-08-27 at 4.35.18 PM.png

Solution

mRNA combined with lipid nanoparticle technology allows for the insertion of lost human proteins back into the human body intravenously.

Commitment to Rare Disease

At Grann Pharmaceuticals, we are dedicated to advancing treatments for rare diseases by working closely with the affected communities. Our focus includes cutting-edge research on Rett syndrome and GABA-A variants, where we collaborate with experts, patients, and families to develop innovative treatments.

 

We are driven by the belief that every rare disease deserves attention and every patient deserves hope, making it our mission to bring transformative solutions to those who need them most.

rare-disease-day-logo.jpg
bottom of page